Clinical Trial Update: A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating single and multiple dose administration of LP-001 in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• LP-001

Snippet

Sponsor: Longbio Pharma | Conditions: Myelodysplastic Syndrome (MDS) | Phase 1 | Status: COMPLETED